Evidence map›Paper›PMID 28031203›Full record

ArticleAntimicrobial agents and chemotherapy2017

PER-8, a Novel Extended-Spectrum β-Lactamase PER Variant, from an Acinetobacter baumannii Clinical Isolate in Nepal.

Tatsuya Tada, Shovita Shrestha, Kayo Shimada, Hiroshi Ohara, Jeevan B Sherchand, Bharat M Pokhrel, Teruo Kirikae

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Laboratory Variants GESAntimicrobial agents and chemotherapy · 2021
    Article
  3. Transposition of TnAntimicrobial agents and chemotherapy · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tatsuya TadaDepartment of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Shovita ShresthaDepartment of Medical Microbiology, Tribhuvan University, Maharajgunj, Kathmandu, Nepal.
Kayo ShimadaDepartment of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan.
Hiroshi OharaDepartment of International Medical-Cooperation, National Center for Global Health and Medicine, Tokyo, Japan.
Jeevan B SherchandDepartment of Medical Microbiology, Tribhuvan University, Maharajgunj, Kathmandu, Nepal.
Bharat M PokhrelDepartment of Microbiology, Institute of Medicine, Tribhuvan University, Maharajgunj, Kathmandu, Nepal.
Teruo KirikaeDepartment of Infectious Diseases, Research Institute, National Center for Global Health and Medicine, Tokyo, Japan tkirikae@ri.ncgm.go.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A novel PER-type extended-spectrum β-lactamase, PER-8, was identified in an

Indexed as

Amino Acid SubstitutionAcinetobacter baumanniiAcinetobacter InfectionsAmino Acid SequenceAnti-Bacterial AgentsAztreonambeta-LactamasesDrug Resistance, Multiple, BacterialHumansImipenemKineticsMicrobial Sensitivity TestsNepalPlasmidsAnti-Bacterial AgentsAztreonambeta-LactamasesImipenemAcinetobacter baumanniiPER-type ESBLsplasmid-mediated resistance

Identifiers

PMID28031203
PMCPMC5328513

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.